Clinical trial

Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake

NCT02517593

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-03-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2016-03-01Date precision: month

Registry last updated2020-12-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Polygenic Risk ScoreGENETIC

Sponsors & collaborators

Mayo Cliniclead sponsor

CancerCare Manitobacollaborator

Mapped research locations

RochesterMinnesota, United States1 WinnipegManitoba, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02517593 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.